Financial insights of BSX

MyFinsight

For the year ending 2025-12-31, BSX made $20,074M in revenue. $2,898M in net income. Net profit margin of 14.44%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Net sales	20,074	16,747	14,240	12,682
Cost of products sold (excluding amortization expense)	6,221	5,257	4,345	3,956
Gross profit	13,854	11,490	9,896	8,727
Selling, general and administrative expenses	6,887	5,984	5,190	4,520
Research and development expenses	2,052	1,615	1,414	1,323
Royalty expense	46	33	46	47
Amortization expense	897	856	828	803
Goodwill impairment charges	-	-	-	0
Intangible asset impairment charges	46	386	58	132
Contingent consideration net expense (benefit)	18	-5	58	35
Restructuring net charges (credits)	101	16	69	24
Litigation-related net charges (credits)	194	0	-111	173
Loss (gain) on disposal of businesses and assets	-	0	0	-22
Operating expenses	10,241	8,887	7,553	7,078
Operating income (loss)	3,613	2,603	2,343	1,649
Interest expense	349	305	265	470
Other, net	121	-16	-93	-38
Income (loss) before income taxes	3,385	2,282	1,985	1,141
Income tax expense (benefit)	493	436	393	443
Net income (loss)	2,892	1,846	1,592	698
Preferred stock dividends	0	0	23	55
Net income (loss) attributable to noncontrolling interests	-6	-8	1	-
Net income (loss) attributable to boston scientific common stockholders	2,898	1,853	1,570	642

Basic	1,480,400,000	1,471,500,000	1,453,000,000	1,430,500,000
Diluted	1,494,500,000	1,485,900,000	1,463,500,000	1,439,700,000
Net income (loss) per common share basic	1.96	1.26	1.08	0.45
Net income (loss) per common share diluted	1.94	1.25	1.07	0.45